secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2021-11-29T23:59:59+00:00
Accession:  0001213900-21-062398
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics prices $30.4M private placement of 8.68M shares and warrants at $3.50/unit.
--------------------------------------------------------------------------------

- Gross proceeds $30.4M from sale of 8.68M shares and accompanying warrants at $3.50 per unit.
- Warrants immediately exercisable at $3.50, expire in 5 yrs; cashless exercise and ownership limits apply.
- EF Hutton receives 9% cash fee plus 1% non-accountable expense fee and up to $70K accountable expenses.
- Proceeds to fund pre-clinical R&D, US/UK clinic businesses, and working capital; resale registration due within 15 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390021062398/0001213900-21-062398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390021062398/ea151423-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-062398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer